MUSC Hollings Cancer Center

Cancer Immunology

cancer immunologyThe scientific goal of the Cancer Immunology Program at the Hollings Cancer Center is to understand the basic mechanisms by which the immune system is regulated in cancer and to apply these discoveries to the development of immunotherapy trials. The three themes of the Cancer Immunology Program are: 1) Cancer Inflammation & Immune Tolerance: the role of inflammation and cross-talk between the innate and adaptive immune systems in cancer; 2) T-Cell Biology & Therapy: T-cell mediated anti-tumor mechanisms and the development and optimization of novel cell-based therapies; and 3) Antibody, Complement, & Transplant-based Therapies: cross-cutting studies into antibody, complement, and transplant-based immunotherapeutic strategies.

Program Leader - Zihai Li, MD, PhD

Cancer Immunology Members

Immunology Program Highlights

HCC Researchers Launch Phase I Trial Combining Two Therapies to Harness Immune System in Advanced Lung Cancer

Researchers Push Frontiers of Immunotherapy, Improve Cancer Treatment





* This website is best viewed in Firefox or Chrome internet browsers.